Internal Medicine, Cardiovascular Disease · Los Angeles, CA
NPI
1558340034
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
8635 W 3rd St, Ste# 695w
Los Angeles, CA, 90048
Phone (310) 967-2140
Groups this clinician bills Medicare through
Medicare paid, 2024
$6.4M
38,095 services
Medicare patients, 2024
2,148
Average age 77
Drug cost, 2024
$1.3M
4,369 prescriptions
Company payments, 2025
$14K
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mehran J Khorsandi was code 99490 (chronic, principal, and transitional care management), 5,285 times for 1,003 patients. In total Mehran J Khorsandi billed 38,095 services in 181 codes, and Medicare paid $6.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-28.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 5,285 | 1,003 | $51.52 | $272K |
| 99214 Office E&M - Established | Office | 3,331 | 1,306 | $103.84 | $346K |
| 93000 Electrocardiogram | Office | 2,801 | 1,312 | $11.64 | $33K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 2,144 | 533 | $5.82 | $12K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 1,066 | 530 | $406.86 | $434K |
| 93306 Echocardiography (TTE/TEE) | Office | 845 | 810 | $147.16 | $124K |
| 37253 Ultrasound - Nonspecific | Office | 772 | 159 | $140.18 | $108K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 722 | 712 | $170.55 | $123K |
| 93970 Duplex Scan - Extremity Veins | Office | 680 | 507 | $148.62 | $101K |
| 93015 Electrocardiogram | Office | 536 | 533 | $63.83 | $34K |
| 78434 Myocardial Perfusion Scan | Office | 533 | 530 | $121.84 | $65K |
| 93925 Duplex Scan - Extremity Arteries | Office | 497 | 443 | $218.78 | $109K |
| 36410 Vascular | Office | 481 | 119 | $7.97 | $3,834 |
| 36247 Angiography | Office | 469 | 115 | $659.58 | $309K |
| 36415 Venipuncture Blood Collection | Office | 442 | 348 | $8.65 | $3,823 |
By year: 2022 $4.4M for 17,505 services; 2023 $6.3M for 25,654 services; 2024 $6.4M for 38,095 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 442 | 348 | $8.65 | $3,823 |
| 80048 Clinical Chemistry | 429 | 341 | $8.29 | $3,556 |
| 85025 Blood Count | 405 | 335 | $7.61 | $3,082 |
| 82306 Clinical Chemistry | 404 | 336 | $29.01 | $12K |
| 83036 Blood Count | 402 | 334 | $9.52 | $3,827 |
| 84443 Clinical Chemistry | 398 | 333 | $16.46 | $6,551 |
| 80061 Clinical Chemistry | 397 | 333 | $13.12 | $5,209 |
| 80076 Clinical Chemistry | 396 | 333 | $8.01 | $3,172 |
| 84439 Clinical Chemistry | 394 | 330 | $8.84 | $3,483 |
| 84481 Clinical Chemistry | 390 | 329 | $16.60 | $6,474 |
Medicare prescription drug claims, 2024
In 2024, the drug Mehran J Khorsandi prescribed most often to Medicare patients was Rosuvastatin Calcium, with 353 prescriptions and refills. In total Mehran J Khorsandi wrote 4,369 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 353 | 773 | 119 | $3,422 |
| Mounjaro Tirzepatide | 300 | 360 | 96 | $368K |
| Clopidogrel Clopidogrel Bisulfate | 225 | 466 | 92 | $1,455 |
| Metoprolol Succinate Generic | 171 | 375 | 69 | $1,340 |
| Carvedilol Generic | 157 | 298 | 51 | $897 |
| Amlodipine Besylate Generic | 152 | 267 | 48 | $449 |
| Repatha Sureclick Evolocumab | 147 | 204 | 40 | $113K |
| Escitalopram Oxalate Generic | 134 | 238 | 45 | $852 |
| Eliquis Apixaban | 132 | 173 | 42 | $102K |
| Losartan Potassium Generic | 127 | 301 | 56 | $855 |
| Amiodarone Hcl Generic | 107 | 172 | 44 | $5,209 |
| Atorvastatin Calcium Generic | 99 | 231 | 41 | $556 |
| Metformin Hcl Generic | 97 | 179 | 34 | $305 |
| Furosemide Generic | 85 | 179 | 39 | $474 |
| Trulicity Dulaglutide | 84 | 117 | 26 | $109K |
Brand drugs: - claims; generic drugs: 3,028 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mehran J Khorsandi $14K ($14K in general payments such as food, travel and fees) from 35 companies. The largest payer was AngioDynamics, Inc. with $5,572.
| Company | Payments | Amount |
|---|---|---|
| AngioDynamics, Inc. ANGO | 22 | $5,572 |
| Abbott Laboratories ABT | 34 | $2,266 |
| CVRx, Inc. CVRX | 25 | $661 |
| Abiomed JNJ | 5 | $527 |
| Boston Scientific Corporation BSX | 21 | $500 |
| E.R. Squibb & Sons, L.L.C. BMY | 29 | $456 |
| Tactile Systems Technology Inc TCMD | 19 | $403 |
| Shockwave Medical, Inc JNJ | 11 | $336 |
| Medtronic, Inc. MDT | 6 | $281 |
| Bard Peripheral Vascular, Inc. BDX | 5 | $268 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.